Ticker Details
Harrow Health, Inc. Common Stock
IPO Date:	October 1, 2007
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$1.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 3.10%
Avg Daily Range (30 D):	$1.06 | 2.74%
Avg Daily Range (90 D):	$1.13 | 2.96%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	989
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$2.75M
Avg Institutional Trade (90 D):	$2.28M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.11M
Avg Closing Trade (30 D):	$3.49M
Avg Closing Trade (90 D):	$2.96M
Avg Closing Volume:	71.27K

News

Jun 10, 2026 @ 11:00 AM Harrow Re-Launches VERKAZIA® (cyclosporine opht... Source: Na

May 27, 2026 @ 11:00 AM Harrow to Present at William Blair’s 46th A... Source: Na

Mar 24, 2026 @ 8:57 PM Harrow Announces Pricing of $50.0 Million Offering... Source: Na

Mar 24, 2026 @ 1:18 PM A Major Investor Just Sold $7.8 Million in Harrow ... Source: Andy Gould

Feb 18, 2026 @ 12:00 PM Harrow To Report Fourth Quarter and Year-End 2025 ... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.74	$.18	$-.14
Diluted EPS	$-.74	$.18	$-.14
Revenue	$44.2M	$89.09M	$272.3M
Gross Profit	$27.05M	$70.62M	$204.37M
Net Income / Loss	$-27.6M	$6.63M	$-5.14M
Operating Income / Loss	$-22.08M	$15.59M	$30.52M
Cost of Revenue	$17.16M	$18.47M	$67.93M
Net Cash Flow	$21.72M	$-1.36M	$25.68M
PE Ratio

Splits
Feb 08, 2013	1:5